Terada Tasuku, Hausen Matheus, Way Kimberley L, O'Neill Carley D, Marçal Isabela Roque, Dorian Paul, Reed Jennifer L
School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
Exercise Physiology and Cardiovascular Health Lab, Division of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
CJC Open. 2025 Mar 3;7(5):695-706. doi: 10.1016/j.cjco.2025.02.017. eCollection 2025 May.
As wearable technologies have become increasingly affordable, accessible, and practical, an increasing number of people with cardiovascular disease are beginning to use consumer-grade devices. Common health and wellness metrics reported by wearable devices include heart rate, heart rhythm, and step count, which may afford opportunities to assess cardiovascular conditions, prescribe more personalized exercise for enhanced engagement, and monitor physical activity adherence in patients with cardiovascular disease. This narrative review discusses the application of wearable devices in patients with coronary artery disease, heart failure, atrial fibrillation (AF), cardiac implantable electric devices, and peripheral artery disease in different cardiovascular rehabilitation settings (eg, supervised and home-based). Available literature suggests that, when combined with telemonitoring, wearable devices can increase physical activity participation, thereby improving peak oxygen consumption ( O) and quality of life (QoL) in patients with coronary artery disease, enhancing physical function and QoL in patients with heart failure, and increasing walking capacity and O in patients with peripheral artery disease. Wearable devices can also detect AF vs sinus rhythm, guide exercise timing in patients with AF, and monitor safe exercise intensity in patients equipped with cardiac implantable electric devices. Healthcare professionals can promote physical activity by incorporating wearable devices, which can help motivate device users by providing real-time feedback on their behaviours. Commercially available wearable devices have the potential to enhance engagement in physical activity, thereby augmenting the established effects of exercise programs on O, functional capacity, and QoL in patients with various cardiovascular conditions.
随着可穿戴技术变得越来越经济实惠、易于获取且实用，越来越多的心血管疾病患者开始使用消费级设备。可穿戴设备报告的常见健康和健身指标包括心率、心律和步数，这可能为评估心血管状况、制定更个性化的运动以提高参与度以及监测心血管疾病患者的体育活动依从性提供机会。这篇叙述性综述讨论了可穿戴设备在不同心血管康复环境（如监督下和居家）中，在冠心病、心力衰竭、心房颤动（AF）、心脏植入式电子设备和外周动脉疾病患者中的应用。现有文献表明，与远程监测相结合时，可穿戴设备可以增加体育活动参与度，从而提高冠心病患者的峰值耗氧量（ O）和生活质量（QoL），增强心力衰竭患者的身体功能和QoL，并增加外周动脉疾病患者的步行能力和 O。可穿戴设备还可以检测房颤与窦性心律，指导房颤患者的运动时间，并监测配备心脏植入式电子设备患者的安全运动强度。医疗保健专业人员可以通过纳入可穿戴设备来促进体育活动，这可以通过提供关于其行为的实时反馈来帮助激励设备用户。市售的可穿戴设备有可能增强体育活动参与度，从而增强运动计划对各种心血管疾病患者的 O、功能能力和QoL的既定影响。
